Home > Healthcare > Medical Devices > Diagnostic Devices > Cardiac Biomarkers Market

Cardiac Biomarkers Market Trends

Report ID: GMI7121
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Cardiac Biomarkers Market Trends

The increasing clinical research efforts dedicated to discovering novel cardiac biomarkers represent a pivotal development in the field of cardiology. These efforts have the potential to transform cardiovascular diagnostics and patient care, enhancing early detection, risk assessment, and the personalization of treatment strategies. As research progresses and novel biomarkers are identified, the future of cardiovascular healthcare is likely to benefit from accurate, comprehensive, and patient-specific approaches to cardiac diagnostics and management.

The trend towards personalized medicine has emphasized the need for biomarkers tailored to individual patient profiles. Clinical research seeks to identify markers that can better predict and monitor cardiac risk on a patient-specific basis.
Conditions such as heart failure with preserved ejection fraction and microvascular dysfunction have created new diagnostic challenges. Research efforts are underway to discover biomarkers specific to these conditions.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The cardiac biomarkers industry was valued at USD 9.4 billion in 2022 and is estimated to account for USD 31.2 billion by 2032.

The troponins segment garnered USD 3 billion revenue size in the year 2022 as the product’s exceptional sensitivity and specificity for cardiac injury make it indispensable in the early detection of myocardial infarction, the monitoring of heart-related disorders, and risk assessment in cardiovascular healthcare.

U.S. market accounted for USD 1.4 billion in 2022 and is predicted to witness substantial growth through 2032, owing to the rising cases of heart diseases in the region.

Abbott Diagnostics, Roche Diagnostics, Siemens Healthineers, Beckman Coulter, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Randox Laboratories, Quidel Corporation, and Radiometer among others.